Skip to main content
Fig. 3 | BMC Pharmacology and Toxicology

Fig. 3

From: β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats

Fig. 3

Effect of β-HPC on liver fibrosis in rats with NASH. A Control group: normal lobular architecture and normal distribution of collagen are shown. B β-HPC group: normal distribution of collagen around the vessels is shown. C Non-treated NASH group: extensive collagen deposition in parenchyma and formation of bridges of collagen in liver tissue were observed. D NASH group treated with 100 mg/Kg β-HPC: showing a reduced deposition of collagen in parenchyma and reduction of the collagen bridge. Representative histological sections of the liver from each group, Masson's trichromic stain, and white arrows showing the presence of collagen (Magnification 4X)

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us